Microvioma

Microvioma is a research-based Organization founded in verified science to participate in WHO's One Health mission by providing microbiology-based solutions.

[Maneesh Paul @maneeshpaul]

Excerpts of my interview today in Economic Times https://t.co/6RPOs96qKo

[Microvioma @microvioma]

"Your mind matters. Let’s celebrate the strength it takes to prioritize mental wellness. Today and every day, mental health is health."
@maneeshpaul #MentalHealthAwareness #MentalHealthDay2024 #MentalHealthDay #gutbrainaxis

https://t.co/G7qE81P2ki

[Microvioma @microvioma]

🌍🌟 Continuing the excitement at @g_sparc, join us on October 5, 2024, for a groundbreaking panel discussion on "Application of AI in Drug Discovery for Developing Novel Antimicrobials", featuring Dr. @maneeshpaul with various esteemed experts.

https://t.co/TlFblQZg23

[Microvioma @microvioma]

🌍 Join Dr. @maneeshpaul, Lead Co-inventor & Program Director for #Enmetazobactam (Orchid Pharma), CEO- @microvioma at the @g_sparc

💡He will be delivering a talk on "Carbapenem sparing new BLI Enmetazobatam (Orblicef™) for treating infections due to ESBL producers."

[Microvioma @microvioma]

Dr. @maneeshpaul, Lead Co-inventor & Program Director for #Enmetazobactam (Orchid Pharma), has been invited as a speaker and panelist at the "Global South Conference on Infection Prevention and Control and Antimicrobial Stewardship" (G-SPARC).

https://t.co/TlFblQZg23

[Microvioma @microvioma]

💡 At the recent @UN High-Level Meeting on #AntimicrobialResistance, Smt. Anupriya Singh Patel, Union Minister of State for Health and Family Welfare, detailed India’s advancements in combating #AMR under its National Action Plan.

https://t.co/0zHUv4mUwp

@maneeshpaul

[Microvioma @microvioma]

Dr. @maneeshpaul will be a featured speaker at the International Masterclass AMR 2024, hosted by AMR Insights, taking place on 26 September 2024 (13:30 – 17:30 CEST) as a digital event accessible globally.

#onehealth #amrinsights @gardp_amr @CCAMP_India @governmentofkar

[Maneesh Paul @maneeshpaul]

🚨 Sepsis affects 50M people & causes 11M deaths yearly! Early detection saves lives! 🏥💉

⚠️ 1 in 5 deaths linked to sepsis.
⚠️ 40% of cases are kids under 5.
⚠️ 50% of survivors have long-term effects.

Raise awareness & fight sepsis! 🙌

#worldsepsisday #fightsepsis

[Maneesh Paul @maneeshpaul]

🌍 Today is World Sepsis Day – a reminder that sepsis claims millions of lives each year. Awareness, prevention, and timely treatment can save lives.

Know the signs: confusion, weakness, rapid breathing, fever. Act fast!

#worldsepsisday #sepsis #who #drpaul #latest #health

[Microvioma @microvioma]

Big step in the fight against #AMR!

#antimicrobialresistance #pandemic #GlobalHealth

[Maneesh Paul @maneeshpaul]

🚨 Big step in the fight against #AMR! 🚨

Bharat Biotech and Alopexx Inc. team up to develop AV0328, a broad-spectrum antimicrobial vaccine targeting 15+ pathogens. Affordable solutions for low & middle-income countries are on the way!

📰 Source: Business Line, 12 Sept'24

[Microvioma @microvioma]

Dr. @maneeshpaul served as the final jury for a competition organized by #KAHPA on #TeachersDay, where he was felicitated by MP Dr. CN Manjunath. He also interacted with prominent academic leaders, highlighting the importance of collaboration in advancing allied health education.

[Microvioma @microvioma]

@microvioma Wishes You a very Happy Teacher’s Day 💐😊

#teachersday #HappyTeachersDay

[Microvioma @microvioma]

⚡️The clock is ticking—without immediate global action, drug-resistant infections could outpace our ability to treat them, leading to millions of preventable deaths. We must invest in antibiotic innovation now to safeguard the future of global health.

https://t.co/8xpUtqHg5T

[Microvioma @microvioma]

✨In Latest News: Global Leaders Unite Under 1-10-100 Goals to Combat Antimicrobial Resistance by 2040
https://t.co/v6IUSgyUmO

1 Health
10 Million Lives Saved
100% Sustainable Access to Effective Antimicrobials:

#antibiotics #AMRACE #antimicrobialstewardship @maneeshpaul

[Microvioma @microvioma]

Exciting News! 🌟

Dr. @maneeshpaul, Co-inventor of #enmetazobactam, CEO- @microvioma will be a speaker at the "Cosmetics Ingredients Expo 2024" in Chennai Trade Centre, Tamil Nadu, on August 30-31, 2024, where he'll delve into “Trends in Functional Cosmetics Ingredients." 🚀

[Microvioma @microvioma]

✨Dr. Maneesh Paul. S., M. Sc., Ph.D., FIDSA., Co-inventor of Enmetazobactam, CEO of Microvioma, will be a panelist at the 10th IPHEX Conference in Noida, India, on August 29, 2024.

[Maneesh Paul @maneeshpaul]

Delighted to share that I'll be one of Panelist at the 10th IPHEX Conference in Noida, India!

Join me on August 29, 2024, from 12:00 to 1:30 pm as we discuss the vital topic of Indian Pharma's Fight Against Antimicrobial Resistance (AMR).
💊🔬

[Microvioma @microvioma]

Latest News✨

The Union Ministry of Health and Family Welfare has issued a significant decision banning 156 fixed dose combination (#FDC) medicines, after they revealed potential health risks, which include #antibiotics, #painkillers, #multivitamins,

https://t.co/GuilvFR93Z

[Microvioma @microvioma]

💡Explore the latest study where researchers developed novel iodine-substituted flavonoids through #greenchemistry that show potent #antimicrobial activity. What area do you think holds the most promise for tackling #AMR?

https://t.co/X5mh3xNXu9

#antibiotics @maneeshpaul

[Microvioma @microvioma]

✨LATEST STUDY✨

💡Lighting Up the #Gut

This study provides a novel approach to #gutmicrobiota imaging using the #fluorescentdyes EF and 6F, with 6F standing out as the better candidate due to its enhanced #fluorescence properties and biocompatibility.

https://t.co/4pFjsPvfv3

[Microvioma @microvioma]

Latest study reveals specific #gutmicrobiome signatures associated with cow's milk allergy (CMA) in children and highlights the potential role of #hypoallergenic formula in promoting oral tolerance.

https://t.co/0HmGKquErF